BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37426418)

  • 1. Pyridylnidulin exerts anti-diabetic properties and improves non-alcoholic fatty liver disease in diet-induced obesity mice.
    Likitnukul S; Tepaarmorndech S; Kaewamatawong T; Yangchum A; Duangtha C; Jongjang P; Mangmool S; Pinthong D; Isaka M
    Front Mol Biosci; 2023; 10():1208215. PubMed ID: 37426418
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of Sitagliptin on Nonalcoholic Fatty Liver Disease in High-fat-diet-fed Diabetic Mice.
    Zhou ST; Cui W; Kong L; Yang X
    Curr Med Sci; 2022 Jun; 42(3):513-519. PubMed ID: 35451807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin ameliorates hepatic steatosis and inflammation without altering adipose phenotype in diet-induced obesity.
    Woo SL; Xu H; Li H; Zhao Y; Hu X; Zhao J; Guo X; Guo T; Botchlett R; Qi T; Pei Y; Zheng J; Xu Y; An X; Chen L; Chen L; Li Q; Xiao X; Huo Y; Wu C
    PLoS One; 2014; 9(3):e91111. PubMed ID: 24638078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGF21 does not require adipocyte AMP-activated protein kinase (AMPK) or the phosphorylation of acetyl-CoA carboxylase (ACC) to mediate improvements in whole-body glucose homeostasis.
    Mottillo EP; Desjardins EM; Fritzen AM; Zou VZ; Crane JD; Yabut JM; Kiens B; Erion DM; Lanba A; Granneman JG; Talukdar S; Steinberg GR
    Mol Metab; 2017 Jun; 6(6):471-481. PubMed ID: 28580278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin treatment reverses high fat diet- induced non-alcoholic fatty liver diseases and dyslipidemia by stimulating multiple antioxidant and anti-inflammatory pathways.
    Yasmin T; Rahman MM; Khan F; Kabir F; Nahar K; Lasker S; Islam MD; Hossain MM; Hasan R; Rana S; Alam MA
    Biochem Biophys Rep; 2021 Dec; 28():101168. PubMed ID: 34825068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice.
    Lee MR; Yang HJ; Park KI; Ma JY
    Phytomedicine; 2019 Mar; 55():14-22. PubMed ID: 30668424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ping-tang Recipe () improves insulin resistance and attenuates hepatic steatosis in high-fat diet-induced obese rats.
    Yang SY; Zhao NJ; Li XJ; Zhang HJ; Chen KJ; Li CD
    Chin J Integr Med; 2012 Apr; 18(4):262-8. PubMed ID: 22457136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of metformin and chlorogenic acid attenuates hepatic steatosis and inflammation in high-fat diet fed mice.
    Zamani-Garmsiri F; Ghasempour G; Aliabadi M; Hashemnia SMR; Emamgholipour S; Meshkani R
    IUBMB Life; 2021 Jan; 73(1):252-263. PubMed ID: 33326684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nrg4 promotes fuel oxidation and a healthy adipokine profile to ameliorate diet-induced metabolic disorders.
    Chen Z; Wang GX; Ma SL; Jung DY; Ha H; Altamimi T; Zhao XY; Guo L; Zhang P; Hu CR; Cheng JX; Lopaschuk GD; Kim JK; Lin JD
    Mol Metab; 2017 Aug; 6(8):863-872. PubMed ID: 28752050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COH-SR4 reduces body weight, improves glycemic control and prevents hepatic steatosis in high fat diet-induced obese mice.
    Figarola JL; Singhal P; Rahbar S; Gugiu BG; Awasthi S; Singhal SS
    PLoS One; 2013; 8(12):e83801. PubMed ID: 24376752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventive and Therapeutic Effects of Krill Oil on Obesity and Obesity-Induced Metabolic Syndromes in High-Fat Diet-Fed Mice.
    Hwang SM; Kim YU; Kim JK; Chun YS; Kwon YS; Ku SK; Song CH
    Mar Drugs; 2022 Jul; 20(8):. PubMed ID: 36005486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JianPi-QingHua formula attenuates nonalcoholic fatty liver disease by regulating the AMPK/SIRT1/NF-κB pathway in high-fat-diet-fed C57BL/6 mice.
    Tian J; Cai M; Jin S; Chen Q; Xu J; Guo Q; Yan Z; Han X; Lu H
    Pharm Biol; 2023 Dec; 61(1):647-656. PubMed ID: 37038833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin decreases high-fat diet-induced renal injury by regulating the expression of adipokines and the renal AMP-activated protein kinase/acetyl-CoA carboxylase pathway in mice.
    Kim D; Lee JE; Jung YJ; Lee AS; Lee S; Park SK; Kim SH; Park BH; Kim W; Kang KP
    Int J Mol Med; 2013 Dec; 32(6):1293-302. PubMed ID: 24068196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tcf7l2 in hepatocytes regulates de novo lipogenesis in diet-induced non-alcoholic fatty liver disease in mice.
    Lee DS; An TH; Kim H; Jung E; Kim G; Oh SY; Kim JS; Chun HJ; Jung J; Lee EW; Han BS; Han DH; Lee YH; Han TS; Hur K; Lee CH; Kim DS; Kim WK; Park JW; Koo SH; Seong JK; Lee SC; Kim H; Bae KH; Oh KJ
    Diabetologia; 2023 May; 66(5):931-954. PubMed ID: 36759348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A refined-JinQi-JiangTang tablet ameliorates prediabetes by reducing insulin resistance and improving beta cell function in mice.
    Gao LH; Liu Q; Liu SN; Chen ZY; Li CN; Lei L; Sun SJ; Li LY; Liu JL; Shen ZF
    J Ethnopharmacol; 2014; 151(1):675-85. PubMed ID: 24286962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise without dietary changes alleviates nonalcoholic fatty liver disease without weight loss benefits.
    Ok DP; Ko K; Bae JY
    Lipids Health Dis; 2018 Sep; 17(1):207. PubMed ID: 30172252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
    Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
    Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perfluorooctanesulfonic Acid (PFOS) Thwarts the Beneficial Effects of Calorie Restriction and Metformin.
    Salter DM; Wei W; Nahar PP; Marques E; Slitt AL
    Toxicol Sci; 2021 Jul; 182(1):82-95. PubMed ID: 33844015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Voluntary exercise in mice fed an obesogenic diet alters the hepatic immune phenotype and improves metabolic parameters - an animal model of life style intervention in NAFLD.
    Gehrke N; Biedenbach J; Huber Y; Straub BK; Galle PR; Simon P; Schattenberg JM
    Sci Rep; 2019 Mar; 9(1):4007. PubMed ID: 30850619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polychlorinated biphenyl 153 is a diet-dependent obesogen that worsens nonalcoholic fatty liver disease in male C57BL6/J mice.
    Wahlang B; Falkner KC; Gregory B; Ansert D; Young D; Conklin DJ; Bhatnagar A; McClain CJ; Cave M
    J Nutr Biochem; 2013 Sep; 24(9):1587-95. PubMed ID: 23618531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.